High-level expression of the coxsackievirus and adenovirus receptor messenger RNA in osteosarcoma, Ewing's sarcoma, and benign neurogenic tumors among musculoskeletal tumors

被引:32
作者
Gu, WG
Ogose, A
Kawashima, H
Ito, M
Ito, T
Matsuba, A
Kitahara, H
Hotta, T
Tokunaga, K
Hatano, H
Morita, T
Urakawa, S
Yoshizawa, T
Kawashima, H
Kuwano, R
Endo, N
机构
[1] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthopaed Surg, Niigata 9518510, Japan
[2] Niigata Univ, Grad Sch Med & Dent Sci, Div Cell Biol & Mol Pharmacol, Niigata 9518510, Japan
[3] Niigata Canc Ctr Hosp, Dept Orthoped Surg, Niigata, Japan
[4] Niigata Univ, Brain Res Inst, Ctr Bioresourcebased Res, Dept Bioinformat,Genome Sci Branch, Niigata 9518510, Japan
关键词
D O I
10.1158/1078-0432.CCR-03-0345
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: The sensitivity of human tumor tissues to infection with recombinant adenoviruses correlates with the expression of the coxsackievirus and adenovirus receptor (CAR). CAR has been shown to function as the primary receptor for adenoviruses and to play a critical role in adenovirus entry into host cells. It is important for clinical gene therapy to determine the expression level of CAR in tumor tissues. Experimental Design: We analyzed the expression of CAR mRNA in 154 musculoskeletal tumor tissues from 154 patients and, 10 normal mesenchymal tissues from 3 patients using reverse transcription-PCR and real-time quantitative PCR. An adenovirus infection assay was performed in two cell lines that were established from CAR-positive osteosarcoma tissue and CAR-negative malignant fibrous histiocytoma tissue. Results: Ninety-nine of 154 tumors were detected as CAR positive by reverse transcription-PCR. We found that the expression levels of CAR mRNA varied markedly between different tumors as determined by real-time quantitative PCR. CAR mRNA was expressed at high levels in osteosarcoma, Ewing's sarcoma, neurofibroma, and schwannoma; at intermediate levels in exostosis, giant cell tumor, liposarcoma, synovial sarcoma, malignant peripheral nerve sheath tumor, and hemangioma; and at low levels in alveolar soft part sarcoma and desmoid. Whereas the osteosarcoma cell line that expressed a high level of CAR mRNA, like its parent tumor, had a high efficiency of adenovirus infection, the malignant fibrous histiocytoma cell line with. almost undetectable expression of CAR mRNA, like its parent tumor, had a low efficiency of infection. Conclusions: Our data showed the great variations in CAR mRNA expression among human musculoskeletal tumors and mesenchymal tissues and implicated the potential usefulness of adenoviral vectors in gene therapy for osteosarcoma, Ewing's sarcoma, neurofibroma, and schwannoma. Efficient transduction with adenovirus for gene therapy could be realized in appropriate, sensitive tumor types.
引用
收藏
页码:3831 / 3838
页数:8
相关论文
共 42 条
[31]  
NOGUERA R, 1992, LAB INVEST, V66, P143
[32]  
Okegawa T, 2000, CANCER RES, V60, P5031
[33]   Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector [J].
Reynolds, PN ;
Dimitriev, I ;
Curiel, DT .
GENE THERAPY, 1999, 6 (07) :1336-1339
[34]   Ewing sarcoma family of tumors express adenovirus receptors and are susceptible to adenovirus-mediated oncolysis [J].
Rice, AM ;
Currier, MA ;
Adams, LC ;
Bharatan, NS ;
Collins, MH ;
Snyder, JD ;
Khan, J ;
Cripe, TP .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2002, 24 (07) :527-533
[35]   Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses [J].
Sandmair, AM ;
Loimas, S ;
Puranen, P ;
Immonen, A ;
Kossila, M ;
Puranen, M ;
Hurskainen, H ;
Tyynelä, K ;
Turunen, M ;
Vanninen, R ;
Lehtolainen, P ;
Paljärvi, L ;
Johansson, R ;
Vapalahti, M ;
Ylä-Herttuala, S .
HUMAN GENE THERAPY, 2000, 11 (16) :2197-2205
[36]   AN ADENOVIRAL VECTOR CAN TRANSFER LACZ EXPRESSION INTO SCHWANN-CELLS IN CULTURE AND IN SCIATIC-NERVE [J].
SHY, ME ;
TANI, M ;
SHI, YJ ;
WHYATT, SA ;
CHBIHI, T ;
SCHERER, SS ;
KAMHOLZ, J .
ANNALS OF NEUROLOGY, 1995, 38 (03) :429-436
[37]   Identification of alternative splice products encoded by the human coxsackie-adenovirus receptor gene [J].
Thoelen, I ;
Magnusson, C ;
Tågerud, S ;
Polacek, C ;
Lindberg, M ;
Van Ranst, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) :216-222
[38]   HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses [J].
Tomko, RP ;
Xu, RL ;
Philipson, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (07) :3352-3356
[39]   An advanced generation of adenoviral vectors selectively enhances gene transfer for ovarian cancer gene therapy approaches [J].
Vanderkwaak, TJ ;
Wang, MH ;
Gómez-Navarro, J ;
Rancourt, C ;
Dmitriev, I ;
Krasnykh, V ;
Barnes, M ;
Siegal, GP ;
Alvarez, R ;
Curiel, DT .
GYNECOLOGIC ONCOLOGY, 1999, 74 (02) :227-234
[40]   Targeting adenovirus [J].
Wickham, TJ .
GENE THERAPY, 2000, 7 (02) :110-114